[European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality]

[Article in French]

Affiliations

[Article in French]

J-L Prugnaud. Nephrol Ther. 2009 Feb.

. 2009 Feb:5 Spec No1:3-5.

doi: 10.1016/S1769-7255(09)70058-6.

¹ Hôpital Saint-Antoine, Service pharmacie, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.

No abstract available

Similar articles

[European legislation on the development of biological similarity: recommendations on the European Agency on Medications with regard to efficacy and safety].
London G. London G. Nephrol Ther. 2009 Feb;5 Spec No1:6-9. doi: 10.1016/S1769-7255(09)70059-8. Nephrol Ther. 2009. PMID: 19233076 French. No abstract available.
European regulatory guidelines for biosimilars.
Wiecek A, Mikhail A. Wiecek A, et al. Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v17-20. doi: 10.1093/ndt/gfl477. Nephrol Dial Transplant. 2006. PMID: 16959790 Review.
The European regulatory experience.
Lewis JA. Lewis JA. Stat Med. 2002 Oct 15;21(19):2931-8. doi: 10.1002/sim.1297. Stat Med. 2002. PMID: 12325109
Development of specifications for biotechnology products--perspective from Europe.
Trouvin JH. Trouvin JH. Dev Biol Stand. 1997;91:25-30. Dev Biol Stand. 1997. PMID: 9413679 Review. No abstract available.
Regulatory environment for allergen-specific immunotherapy.
Kaul S, May S, Lüttkopf D, Vieths S. Kaul S, et al. Allergy. 2011 Jun;66(6):753-64. doi: 10.1111/j.1398-9995.2011.02552.x. Epub 2011 Feb 3. Allergy. 2011. PMID: 21288251 Review.